Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

Karolinska University Hospital, Stockholm, Sweden.

Survival: monthsCountry:Sweden
Toxiciy Grade:5City/State/Province:Stockholm
Treatments:ChemotherapyHospital:Karolinska University Hospital
Drugs:Journal:Link
Date:Nov 2008

Description:

Patients:
This phase 2 study involved 173 patients with malignant pleural mesothelioma who had not received prior chemotherapy. The mean patient age was 62.8 years and 90.8% were male.

Treatment:
Patients were treated with the chemotherapy agents gemcitabine, carboplatin, and liposomal-encapsulated doxorubicin.

Toxicities:
Three treatment-related deaths due to neutropenic sepsis (infection) were reported. Grade 4 thrombocytopenia and alopecia were also reported.

Results:
The median overall survival was 13 months.

Correspondence: Dr. Gunnar Hillerdal; email: [email protected]



Back